Allergy Therapeutics (AGY)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

11.70p
   
  • Change Today:
    -0.100p
  • 52 Week High: 12.10
  • 52 Week Low: 5.25
  • Currency: UK Pounds
  • Shares Issued: 6,332m
  • Volume: 92,780
  • Market Cap: £740.91m
  • RiskGrade: 268
  • Beta: 0.00

Latest ShareCast News

Results of General Meeting

By Sharecast

Date: Monday 29 Dec 2025

AGY ShareCast News

Allergy Therapeutics starts dosing peanut allerg... 27-Mar-2023 ShareCast
Allergy Therapeutics confident in funding as res... 20-Jan-2023 ShareCast
Allergy Therapeutics pauses production at Freema... 04-Oct-2022 ShareCast
Allegy Therapeutics trades 'robustly' in tough y... 15-Jul-2022 ShareCast
Allergy Therapeutics reports positive results fr... 25-Oct-2021 ShareCast

AGY Regulatory News

Update on funding and total voting rights 23-Feb-2026 07:51 RNS
Chief Strategy Officer and Board appointments 30-Jan-2026 08:22 RNS
Result of Annual General Meeting 29-Jan-2026 14:13 RNS
Grant of Options under Long Term Incentive Scheme 28-Jan-2026 16:48 RNS
Half Year Trading Update 19-Jan-2026 07:00 RNS

AGY Newspaper Links

Allergy drug firm hit by trials setback 12-Jul-2007 The Independent
Need to Know: Global Business Briefing 25-Mar-2006 Times

AGY Tips & Analysis

FTSE Close: BP and Lloyds lead rally 21-Sep-2010 Daily Mail
Tempus:Allergy Therapeutics 22-Sep-2009 Times
Investment Column:Allergy Therapeutics 22-Sep-2009 The Independent
Market report: Wednesday lastest 14-May-2008 Daily Mail
Market Report: Prudential gains after bid specul... 13-Mar-2008 The Independent

AGY News Wires

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AGY Market Data

Currency UK Pounds
Share Price 11.70p
Change Today -0.100p
% Change -0.85 %
52 Week High 12.10
52 Week Low 5.25
Volume 92,780
Shares Issued 6,332m
Market Cap £740.91m
Beta 0.00
RiskGrade 268

AGY Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
68.95% below the market average68.95% below the market average68.95% below the market average68.95% below the market average68.95% below the market average
65.85% below the sector average65.85% below the sector average65.85% below the sector average65.85% below the sector average65.85% below the sector average
Price Trend
93.47% above the market average93.47% above the market average93.47% above the market average93.47% above the market average93.47% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Income Not Available
Growth
53.41% below the market average53.41% below the market average53.41% below the market average53.41% below the market average53.41% below the market average
79.31% below the sector average79.31% below the sector average79.31% below the sector average79.31% below the sector average79.31% below the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AGY Dividends

No dividends found

Trades for 03-Mar-2026

Time Volume / Share Price
16:35 20,000 @ 11.70p
16:35 5,000 @ 11.70p
16:35 15,000 @ 11.70p
15:33 3,749 @ 12.00p
15:19 12,208 @ 10.76p

AGY Key Personnel

CEO Manuel Llobet

Top of Page